Inhibition of adenosine deaminase by co-vidarabine and its effect on the metabolic disposition of adenine arabinoside (vidarabine).
D058892:Adenosine Deaminase Inhibitors; D000818:Animals; D001798:Blood Proteins / Q000378:metabolism; D004347:Drug Interactions; D004912:Erythrocytes / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D007700:Kinetics; D008297:Male; D009700:Nucleoside Deaminases / Q000037:antagonists & inhibitors*; D011485:Protein Binding; D051381:Rats; D014018:Tissue Distribution; D014740:Vidarabine / Q000031:analogs & derivatives* / Q000378:metabolism* / Q000494:pharmacology
D058892:Adenosine Deaminase Inhibitors; D001798:Blood Proteins; D009700:Nucleoside Deaminases; D014740:Vidarabine